Advanced in Endometrial Stromal Sarcoma

Dr. Mark J. Messing

Oncology | Obstetrics and Gynecology
Baylor Scott & White Health
Texas Oncology, P.A.
1615 Hospital Parkway, Suite 300, 
Bedford, TX 
Offers Telehealth
42 Years of Experience
Advanced in Endometrial Stromal Sarcoma
Baylor Scott & White Health
Texas Oncology, P.A.
1615 Hospital Parkway, Suite 300, 
Bedford, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Messing is an Oncologist and an Obstetrics and Gynecologist in Bedford, Texas. Dr. Messing has been practicing medicine for over 42 years and is rated as an Advanced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Desmoplastic Small Round Cell Tumor, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Emory University School Of Medicine, 1984.0
Residency
OB/GYN, University of Alabama
Specialties
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in TX
Board Certifications
The American Board Of Obstetrics & Gynecology
Fellowships
Gynecologic Oncology, University of Texas MD Anderson Cancer Center
Gynecological Oncology, University of Texas MD Anderson Cancer Center
Hospital Affiliations
Baylor Scott & White Medical Center Grapevine
Texas Health Harris Methodist Hurst-Euless-Bedford
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Texas Oncology, P.A.
1615 Hospital Parkway, Suite 300, Bedford, TX 76022
Call: 817-678-8031

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ®) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors
A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ®) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: December 16, 2025
Intervention Type: Drug
Study Drugs: TJ004309, Atezolizumab
Study Phase: Phase 2
FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects With Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects With Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Enrollment Status: Terminated
Publish Date: March 24, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drugs: AGEN-2034 PD-1 Antibody, AGEN-1884 CTLA4 Antibody
Study Phase: Phase 2
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
A Phase 1b/2, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients With Solid Tumors Likely to Express NaPi2b
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Upifitamab rilsodotin
Study Phase: Phase 1/Phase 2
A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Enrollment Status: Terminated
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

3 Total Publications

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.
Journal: Journal for immunotherapy of cancer
Published: December 04, 2023
View All 3 Publications
Similar Doctors
Distinguished in Endometrial Stromal Sarcoma
Dr. Deette R. Vasques
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Deette R. Vasques
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Oncology-Hematology Consultants PA

6100 Harris Pkwy, Suite 235, 
Fort Worth, TX 
 (21.0 miles away)
817-759-7000
Languages Spoken:
English, Hindi, Mandarin, Spanish, Taiwanese
See accepted insurances
Accepting New Patients
Offers Telehealth

Deette Vasques is a Gynecologic Oncologist and an Oncologist in Fort Worth, Texas. Dr. Vasques is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Vulvectomy, and Ureteroscopy. Dr. Vasques is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma
Dr. Erik C. Koon
Obstetrics and Gynecology | Oncology
Distinguished in Endometrial Stromal Sarcoma
Dr. Erik C. Koon
Obstetrics and Gynecology | Oncology

Texas Oncology, P.A.

3410 Worth Street, Suite 400, 
Dallas, TX 
 (20.4 miles away)
972-449-0540
Experience:
28+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Erik Koon is an Oncologist and an Obstetrics and Gynecologist in Dallas, Texas. Dr. Koon has been practicing medicine for over 28 years and is rated as an Advanced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Distinguished in Endometrial Stromal Sarcoma
Dr. Thomas P. Heffernan
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Thomas P. Heffernan
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Oncology-Hematology Consultants PA

12200 Park Central Dr, 
Dallas, TX 
 (21.1 miles away)
972-490-5970
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Thomas Heffernan is a Gynecologic Oncologist and an Oncologist in Dallas, Texas. Dr. Heffernan is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Heffernan is currently accepting new patients.

VIEW MORE ENDOMETRIAL STROMAL SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Messing's expertise for a condition
ConditionClose
    • Distinguished
    • Desmoplastic Small Round Cell Tumor
      Dr. Messing is
      Distinguished
      . Learn about Desmoplastic Small Round Cell Tumor.
      See more Desmoplastic Small Round Cell Tumor experts
    • Endometrial Cancer
      Dr. Messing is
      Distinguished
      . Learn about Endometrial Cancer.
      See more Endometrial Cancer experts
    • Malignant Mixed Mullerian Tumor
      Dr. Messing is
      Distinguished
      . Learn about Malignant Mixed Mullerian Tumor.
      See more Malignant Mixed Mullerian Tumor experts
    • Ovarian Cancer
      Dr. Messing is
      Distinguished
      . Learn about Ovarian Cancer.
      See more Ovarian Cancer experts
    • Ovarian Carcinosarcoma
      Dr. Messing is
      Distinguished
      . Learn about Ovarian Carcinosarcoma.
      See more Ovarian Carcinosarcoma experts
    • Sertoli-Leydig Cell Tumor
      Dr. Messing is
      Distinguished
      . Learn about Sertoli-Leydig Cell Tumor.
      See more Sertoli-Leydig Cell Tumor experts
    View All 8 Distinguished Conditions
    • Advanced
    • Cervical Cancer
      Dr. Messing is
      Advanced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Endometrial Stromal Sarcoma
      Dr. Messing is
      Advanced
      . Learn about Endometrial Stromal Sarcoma.
      See more Endometrial Stromal Sarcoma experts
    • Lump in the Abdomen
      Dr. Messing is
      Advanced
      . Learn about Lump in the Abdomen.
      See more Lump in the Abdomen experts
    • Neonatal Ovarian Cyst
      Dr. Messing is
      Advanced
      . Learn about Neonatal Ovarian Cyst.
      See more Neonatal Ovarian Cyst experts
    • Neuroendocrine Carcinoma of the Cervix
      Dr. Messing is
      Advanced
      . Learn about Neuroendocrine Carcinoma of the Cervix.
      See more Neuroendocrine Carcinoma of the Cervix experts
    • Ovarian Cysts
      Dr. Messing is
      Advanced
      . Learn about Ovarian Cysts.
      See more Ovarian Cysts experts
    View All 8 Advanced Conditions
    • Experienced
    • Adenomyosis
      Dr. Messing is
      Experienced
      . Learn about Adenomyosis.
      See more Adenomyosis experts
    • Angiomyoma
      Dr. Messing is
      Experienced
      . Learn about Angiomyoma.
      See more Angiomyoma experts
    • Breast Cancer
      Dr. Messing is
      Experienced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Cervicitis
      Dr. Messing is
      Experienced
      . Learn about Cervicitis.
      See more Cervicitis experts
    • Endometrial Polyps
      Dr. Messing is
      Experienced
      . Learn about Endometrial Polyps.
      See more Endometrial Polyps experts
    • Endometritis
      Dr. Messing is
      Experienced
      . Learn about Endometritis.
      See more Endometritis experts
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.